How Many People with Hashimoto's Disease Win SSDI — and What Drives the Outcome

Hashimoto's thyroiditis is the most common autoimmune thyroid condition in the United States. Most people manage it with medication and live relatively normal lives. But for a subset of claimants, Hashimoto's produces symptoms severe enough to interfere with the ability to work — and that's the core question SSDI is built to answer.

There's no published approval rate specifically for Hashimoto's disease. The Social Security Administration (SSA) doesn't report win rates by diagnosis. What it does report — and what advocates and disability attorneys track closely — is that overall initial approval rates hover around 20–30%, with higher rates at the ALJ hearing stage for claimants who appeal. Hashimoto's claims follow the same pattern: the diagnosis alone doesn't determine the outcome. The severity and documented impact do.

Why Hashimoto's Is Rarely a Simple Approval

Hashimoto's is an autoimmune condition where the immune system attacks the thyroid gland, often leading to hypothyroidism. The SSA is well aware that many people with hypothyroidism — including Hashimoto's — are effectively treated with levothyroxine and maintain full or near-full function.

This creates an immediate evaluation challenge: the SSA reviews what you cannot do, not just what you have been diagnosed with.

Claimants whose thyroid levels are well-controlled on medication face a harder road. The SSA's evaluators — called Disability Determination Services (DDS) examiners at the initial and reconsideration stages — will look at whether the condition still produces functional limitations despite treatment.

What the SSA Actually Evaluates

The SSA does not have a specific "Blue Book" listing for Hashimoto's disease alone. It may be evaluated under:

• Section 9.00 – Endocrine Disorders, which covers thyroid conditions but sets a high bar for listing-level severity
• Thyroid-related listings that require specific lab evidence, persistent symptoms, or complications despite treatment
• Other body system listings if Hashimoto's has caused secondary complications — such as cardiac involvement, neurological effects, or another autoimmune condition

Most Hashimoto's SSDI cases don't meet a listing directly. They succeed — when they do — through what's called the medical-vocational allowance route.

The Medical-Vocational Path

If a claimant doesn't meet or equal a Blue Book listing, the SSA assesses their Residual Functional Capacity (RFC) — a formal determination of the most work-related activity they can still perform despite their impairments.

The RFC considers:

• How much can the person lift, carry, sit, stand, or walk?
• Are there cognitive limitations — brain fog, concentration problems, memory issues?
• Are there absences, fatigue patterns, or pain that would disrupt a regular work schedule?

With Hashimoto's, the symptoms most likely to support RFC limitations include chronic fatigue, joint pain, cognitive dysfunction ("brain fog"), depression, and cold intolerance. These are real and documented in medical literature — but they must be documented in the claimant's own medical records, not just described by the claimant at a hearing.

Once RFC is established, the SSA applies what's known as the medical-vocational grid rules, weighing age, education, and past work history to determine whether the claimant can perform any work that exists in significant numbers in the national economy.

Comorbidities Change the Picture Significantly 🔍

Hashimoto's rarely travels alone. It commonly co-occurs with:

• Other autoimmune conditions (lupus, rheumatoid arthritis, Sjögren's syndrome)
• Depression and anxiety
• Fibromyalgia
• Chronic fatigue syndrome

When multiple conditions combine to limit function, the SSA is required to consider their combined effect on a claimant's RFC. A Hashimoto's claim that might not succeed on its own can be significantly strengthened by documented comorbidities — provided all conditions are consistently treated and recorded in the medical file.

The Role of Work Credits and Program Eligibility

Before any medical evaluation begins, an SSDI applicant must pass the non-medical eligibility test. SSDI is an earned benefit funded through payroll taxes. To qualify, a claimant must have accumulated sufficient work credits — generally 40 credits, with 20 earned in the last 10 years, though younger workers need fewer.

SSI (Supplemental Security Income) is a separate program with no work-credit requirement but with strict income and asset limits. Some Hashimoto's claimants apply for both programs simultaneously, depending on their situation.

What Stage of the Process You're In Matters ⚖️

Approval rates vary significantly by stage:

• Initial application: Roughly 20–30% approval nationally
• Reconsideration: Approval rates drop further — many claimants are denied again
• ALJ hearing: Historically the most productive stage, with approval rates often cited in the 45–55% range nationally
• Appeals Council and federal court: Much lower approval rates; usually pursued on narrow legal grounds

For Hashimoto's claimants with well-documented, severe symptoms, the ALJ hearing stage — where a judge reviews the full medical record and hears testimony — tends to produce more nuanced decisions than early-stage DDS review.

The Missing Piece Is Always the Individual Record

A Hashimoto's diagnosis opens the door to an SSDI claim. What happens next depends on how severe the functional limitations are, how thoroughly they're documented, how long the claimant has been unable to meet Substantial Gainful Activity (SGA) thresholds (which adjust annually), and what the work and medical history shows across years of treatment.

Two people with the same diagnosis can produce entirely different outcomes. That gap — between understanding how the program works and knowing where your own record stands — is where every Hashimoto's SSDI case actually lives.